Trial
NCT03747419
Avelumab and Radiation in Muscle-Invasive Bladder Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
EMD Serono
Condition
Bladder Cancer
Intervention
Avelumab
Why stopped
In agreement with the drug sponsor and the institution, the trial has been terminated due to slow accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-31